您当前的位置:
Ginsenoside Rh2. (Synonyms: 人参皂苷 Rh2; 20(S)-Ginsenoside Rh2; 20(S)-Rh2; Ginsenoside-Rh2)
目录号: PC64080 纯度: ≥98%
CAS No. :78214-33-2
商品编号 规格 价格 会员价 是否有货 数量
PC64080-5mg 5mg ¥475.00 请登录
PC64080-10mg 10mg ¥712.50 请登录
PC64080-25mg 25mg ¥1425.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Ginsenoside Rh2.
中文别名
人参皂苷 Rh2;人参皂苷-RH2;(R型)人参皂苷RH2;人参皂荚RH2;人参皂苷 S-RH2;人参皂苷RH2(标准品);人参皂甙 Rh2;(20S)人参皂苷 Rh2;(S型)人参皂苷Rh2;20(S)-人参皂苷Rh2;20(S)-人参皂苷-RH2;20(S)-人参皂苷-RH2,20(S)-Ginsenoside-RH2,植物提取物,标准品,对照品;S-人参皂苷Rh2;人参皂甙 Rh2 Ginsenoside Rh2;人参皂苷 Rh2 (S-FORM)(AS);人参皂苷 Rh2 (S-FORM)(P);人参皂苷Rh2 对照品标准品;人参皂苷Rh2 标准品;人参皂苷Rh2(S);人参皂苷Rh2(人参皂苷S- Rh2 、20(S)-人参皂苷RH2);人参皂苷Rh2对照品;分析对照品
英文名称
Ginsenoside Rh2
英文别名
Ginsenoside Rh2;(3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-d-glucopyranoside;dihydroxydammar-24-en-3-yl;β-D-Glucopyranoside, (3β,12β)-12,20-;R-form-Ginsenoside Rh2;12β,20-Dihydroxy-5α-dammar-24-en-3β-yl β-D-glucopyranoside;3β-(β-D-Glucopyranosyloxy)dammara-24-ene-12β,20-diol;20(S)-Ginsenoside Rh2;20-(S)-GinsenosideRh2;GINSENOSIDE Rh2 (S-FORM)(AS) PrintBack;(3β,12β)-12,20-Dihydroxydammar-24-en-3-yl-β-D-glucopyranoside;20(S)-Rh2;ginenoside Rh2;Ginsenoside-Rh2;20(S)-Ginsenoside-Rh2;2-[[(8R,10R,14R)-12-Hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5
Cas No.
78214-33-2
分子式
C36H62O8
分子量
622.87
包装储存
Powder; -20°C; 3 years; 4°C; 2 years;
生物活性
Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.
性状
Solid
IC50 & Target[1][2]
Caspase-8
 Caspase-9
 
体外研究(In Vitro)
Ginsenoside Rh2 induces the activation of two initiator caspases, caspase-8 and caspase-9 in human cancer cells. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner and is therefore a promising candidate for anti-tumor drug development. Ginsenoside Rh2 triggers p53-dependent Fas expression and consequent activation of caspase-8 and p53-independent caspase-9-mediated intrinsic pathway to cause cancer cell death.The cytotoxic activity of Ginsenoside Rh2 in the human tumor cell lines HeLa, SK-HEP-1, SW480, and PC-3 is assessed by MTT. The cell viability of HeLa cells is remarkably inhibited by Ginsenoside Rh2, with an IC50 value of 2.52 μg/mL, whereas SK-HEP-1 and SW480 cells are less sensitive to Ginsenoside Rh2, with IC50 values of 3.15 μg/mL and 4.06 μg/mL, respectively. PC-3 cells are the least vulnerable to Ginsenoside Rh2, with an IC
体内研究(In Vivo)
A total of 15 days following B16-F10 cell injection, tumor sizes from the 3 tumor bearing groups are measured. The tumor sizes in the G-L group and G-H group (G-L and G-H refer to a low or high dose of ginsenoside Rh2 injection) are reduced compared with the tumor group (P<0.05). The survival analysis reveals that the Ginsenoside Rh2 treated groups survive longer than the untreated tumor group and the effect is dose-dependent (P<0.05).Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
结构分类
Terpenoids
Triter
来源
Plants
溶解度数据
体外研究:
DMSO : 50 mg/mL(80.27 mM;Need ultrasonic)
配制储存液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2